Inventor · disambiguated record
Ping Chen
Also filed as: CHEN PING · CHEN PING-KUEN
7 granted patents·1 pending application·7 citations·filing 2002–2022
76Inventor score
Files withMAYO FOUND MEDICAL EDUCATION & RES4CARLSBAD TECHNOLOGY INC1SHENZHEN AUSA PHARMED CO LTD1YUNG SHIN PHARMACEUTICAL IND1
Top patents by PatentIndex Score
8 records- 0180US11473069B2Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelinMAYO FOUND MEDICAL EDUCATION & RES·Filed 2019·Granted Oct 18, 2022·1 cites·6 claims
- 0277US12116602B2Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelinMAYO FOUND MEDICAL EDUCATION & RES·Filed 2022·Granted Oct 15, 2024·0 cites·10 claims
- 0373US10301609B2Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelinMAYO FOUND MEDICAL EDUCATION & RES·Filed 2015·Granted May 28, 2019·1 cites·7 claims
- 0472US6902746B2Oral pharmaceutical compositions containing non-steroidal anti-inflammatory drugs and method for preparing the sameYUNG SHIN PHARMACEUTICAL IND·Filed 2002·Granted Jun 7, 2005·4 cites·16 claims
- 0562US6673373B2Antifungal formulation and the methods for manufacturing and using the sameCARLSBAD TECHNOLOGY INC·Filed 2002·Granted Jan 6, 2004·1 cites·34 claims
- 0652US11865163B2Methods and materials for using butyrylcholinesterases to treat cancerMAYO FOUND MEDICAL EDUCATION & RES·Filed 2017·Granted Jan 9, 2024·0 cites·11 claims
- 0749US12336978B2Pharmaceutical composition containing amlodipine, chlorthalidone, and amiloride and application thereofSHENZHEN AUSA PHARMED CO LTD·Filed 2021·Granted Jun 24, 2025·0 cites·18 claims
- 0840US2004180898A1Processes for preparing imidazoquinoxalinones, heterocyclic-substituted imidazopyrazinones, imidazoquinoxalines and heterocyclic-substituted imidazopyrazinesFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ping Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →